Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Tab Title Description
The purpose of this study is to establish a robust, prospective database to assess longitudinal outcomes for patients with small PNETS as well as assess patient-reported outcomes through virtual distribution of surveys.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Pancreas mass ≤ 20 mm in size
Mass localized to the pancreas
Exclusion Criteria:
Biopsy-proven adenocarcinoma prior to enrollment
Confirmed metastatic disease
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 01/02/2026. Questions regarding updates should be directed to the study team contact.
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic principal investigator
Jad AbiMansour, M.D.
Open for enrollment
Jad AbiMansour
Contact Usabimansour.jad@mayo.edu